Formation of sulphmyoglobin during expression of horse heart myoglobin in Escherichia coli  by Lloyd, Emma & Mauk, A.Grant
FEBS Letters 340 (1994) 281-286 
LETTERS 
ELSEVIER 
FEBS 13770 
Formation of sulphmyoglobin during expression of horse heart myoglobin 
in Escherichia coli 
Emma Lloyd, A. Grant Mauk* 
Department of Biochemistry and Molecular Biology and the Protein Engineering Network of Centres of Excellence, University of British Columbia, 
Vancouver, BC, V6T 123. Canada 
Received 17 December 1993; revised version received 4 February 1994 
Abstract 
Expression of recombinant horse heart myoglobin in Escherichia coli has been found to result in the production of both native and variable amounts 
(- 1617% total) of two sulphmyoglobin isomers. The recombinant sulphmyoglobin produced consists primarily of the A and B isomers as identified 
by ‘H NMR spectroscopy with no evidence for production of the C isomer. Conversion of recombinant sulphmyoglobin to the native protein can 
be achieved by reconstitution with protohaem IX. The possible relationship of this observation to recombinant expression of other heme proteins 
is discussed. 
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1. Introduction 
In recent years, efficient expression of genes coding for 
human [l], sperm whale [2], porcine [3], and horse heart 
[4] myoglobin (Mb) in Escherichiu coli has been reported. 
In our work concerning recombinant forms of horse 
heart Mb, we have frequently observed that the trans- 
formed bacterial cultures producing this protein can as- 
sume a bright green colour. In addition, the electronic 
absorption spectra of the wild-type and variant forms of 
Mb purified from these cultures can exhibit absorption 
maxima that are not characteristic of the wild-type pro- 
tein. As amino acid substitutions at the active site of Mb 
might reasonably be expected to produce changes in the 
electronic spectrum of the protein, it is important to 
establish whether new spectroscopic features result from 
the amino acid substitution itself or from some chemical 
modification of the protein inherent in the expression 
system. 
The green colour of the cultures and the spectroscopic 
properties of the purified protein led us to suspect that 
expression of horse heart Mb in E. cofi results in 
sulphmyoglobin (sulphMb) formation, a derivative of 
Mb that is distinguished by its green colour (e.g. refer- 
ence [5]). The formation of sulphMb in vitro is achieved 
by the action of inorganic sulphides on ferry1 Mb 
(Fe(IV) = 0) [5]. 
*Corresponding author. Fax: (1) (604) 822 6860. 
metMb + H202 + ferrylMb 
ferrylMb + H,S + Fe(III)sulphMb 
NMR studies have demonstrated that in vitro prepara- 
tions of sulphMb give rise to a heterogeneneous mixture 
of at least three major products that cannot be distin- 
guished by electronic spectroscopy but that exhibit char- 
acteristic NMR spectra [&lo] particularly in the cy- 
anmet form of the protein. The initial product, S,Mb, is 
consistent with addition of a sulphur atom as an epi- 
sulphide across the /I-/3 bond of pyrole II of the proto- 
porphyrin IX group, Fig. 1A. Under acidic conditions 
this product decays predominantly to SBMb, the struc- 
ture of which is uncertain but has been proposed to be 
as depicted in Fig. 1 B [lo]. Under basic conditions decay 
of SAMb yields mainly &Mb, the thermodynamically 
stable product [6,7,10], which has been shown to contain 
a chlorin prosthetic group in which the vinyl group of 
pyrole II has formed an exocyclic thiolene ring [8,9], Fig. 
1C. In addition, a number of pharmaceutical agents can 
produce sulphhemoglobin derivatives of undetermined 
but presumably related structures in vivo [l 11. 
To determine whether or not sulphMb is produced 
during expression of recombinant horse heart Mb in E. 
coli, we have studied the electronic and NMR spectra of 
recombinant Mb preparations in which significant quan- 
tities of the contaminant are present. We find that 
sulphMb can, in fact, form during bacterial expression 
of horse heart Mb, and discuss the possible implications 
of this and related findings for the bacterial expression 
of haemproteins in general. 
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2. Experimental 
2.1 Fermentation 
Expression of a synthetic gene for horse heart Mb in Escherichia co11 
has been described [4]. LE392 cells (supE44, supF58, lac Yl, galk2, gal 
T22, mt BI, Trp R55, lambda-) containing the pGYM plasmid were 
grown in superbroth (tryptone (10 g/l)(BDH), yeast extract (8 g/ 
l)(BDH), NaCl (5 g/l)(BDH) and ampicillin (100 ,@ml) (Sigma)). 
Preparative scale cultures (600 ml) were grown (18 h) in 2-liter Erlen- 
meyer flasks placed in a shaker-incubator (37°C). After harvesting by 
centrifugation, the cells were resuspended in 20 mM Tris-HCl pH 8.0, 
and lysozyme (250 mg, Sigma) was added. The cells were shaken at 4’C 
until the suspension became viscous, and the lysed cells were then 
frozen until needed. In general, bacteria grown in the flasks produced 
cultures that varied in colour from bright green to red. For the discus- 
sion below, Mb isolated from the green and red coloured cultures is 
referred to as ‘green’ and ‘red’ Mb, respectively. 
2 2. Protein purl&ation 
Commercial horse heart Mb (Sigma Ml882) was chromatographi- 
tally purified as described by Tomoda et al. [12]. Wild-type recombi- 
nant Mb was purified as previously described [4] except hat the crude 
Mb extract was loaded onto a column of DEAE Sepharose CMB 
(Pharmacia) (3 x 15 cm) equilibrated in 20 mM Tris-HCl pH 8.0. Myo- 
globin does not bind to this resin under these conditions, so fractions 
eluting directly from the column were loaded onto a column of 
Chelating Sepharose Fast Flow (Pharmacia) (3 x 10 cm) prepared by 
sequentially washing with water (300 ml). SO mM ethylenediamine- 
tetraaceticacid (300 ml), a solution of 35 mM ZnSO, that contained 
25 mM acetic acid (300 ml). and buffer (20 mM Tris-HCl. 0.5 M NaCl. 
pH 8.0) (300 ml). After binding Mb to this column, it was washed with 
20 mM Tris-HCl(O.5 M NaCl, pH 8.0) (200 ml) before developmg with 
20 mM Tris-HCl(O.5 M NaCl, SO mM imidazole pH 8.0) (100 ml). The 
partially purified Mb was then concentrated by centrifugal ultrafiltra- 
tion (Centriprep-IO, Amicon) to a volume of - 15 ml and loaded onto 
a column of’ Sephadex G-50 (Pharmacia) equilibrated and eluted with 
20 mM Tris-HC1 containine 1 mM EDTA (oH 8.0) for further nurifica- 
tion. Myoglobin fractions (%,&A 280 2 3Sywere pooled and exchanged 
into 20 mM ethanolamine (pH 9.0). Final purification of the Mb was 
achieved by elution over an HRlO/lO Mono-Q anion-exchange column 
(Pharmacta) that was initially equilibrated with 20 mM ethanolamine 
pH 9.0 and developed with a linear gradient of NaCl (O-0.06 M). The 
final product (A,,,/A,,O 2 3.5) migrated as a single band by SDS- 
PAGE. Separation of green and red Mb was not achieved by the FPLC 
method described above. 
MetMb was prepared by addition of four equivalents of potassium 
ferricyanide, and excess oxidant was removed by anion exchange chro- 
matograpy [13]. ApoMb was prepared as previously described [14] 
(szgO = 16 mM-‘cm-’ [IS]). ApoMb in sodium phosphate buffer (pH 7, 
fi = 0.10 M) was reconstituted by addition of 1.1 equivalents of iron 
protoporphyrin IX (10 mg/ml in 0.2 M NaOH) (Porphyrin Products, 
Logan, Utah) followed by elution over a column of Sephadex G-SO 
(2.5 x 75 cm). Reconstituted protein for NMR analysis was stored at 
4°C prior to use to allow for reorientatton of the haem group [ 16,171. 
SulphMb was prepared as described previously [18]. 
2.3. NMR and mass spectrometry 
Electrospray mass spectrometry was performed with a triple quad- 
rupole mass spectrometer (API III MS/MS system; Sciex, Thornhill. 
Ontario, Canada) fitted with a pneumatically assisted electrospray m- 
terface [19]. Samples of native and unreconstitued recombinant Mb 
were prepared in water (SO ,ul, 1 mg/ml). NMR spectra were recorded 
at 20°C with a Bruker MSL-200 suectrometer. Protein solutions I- 2 
mM) were exchanged into SO mM deuterated sodium phosphate buffer 
pH 7.0 (uncorrected pH meter reading). 
3. Results 
3.1. Mass spectrometry 
The molecular mass determined by electrospray mass 
spectrometry of apoMb from native Mb was 
16951.7 k 2.0, which compares to a mass of 16950.5 pre- 
dicted from the amino acid sequence. For the recombi- 
nant sample, two principal molecular ions were identi- 
fied with masses of 16950.5 + 3.5 and 17083.4 3.1. 
These values correspond to the mass of the apo-protein 
and to the mass of the apo-protein plus the N-terminal 
methionine, respectively. The molecular masses of the 
red and green Mbs determined in this manner were iden- 
tical. Mass spectrometry of the prosthetic groups of these 
derivatives was not attempted. 
3.2. Electronic absorption spectra 
The electronic spectra of native horse heart Mb in the 
met-aquo, deoxy and carbonyl forms are shown in Fig. 
2A. Examination of the corresponding spectra of puri- 
fied green and red Mbs (Fig. 2B and C; Table 1) reveals 
spectra that differ substantially from those of the native 
protein. These differences are most pronounced for the 
deoxy and carbonyl derivatives. The Soret absorbancies 
of the green and red Mbs exhibit maxima intermediate 
between those expected for native Mb and sulphhlb, as 
anticipated for a mixture of two forms. Similar spectra 
A B C 
Fig. 1. Proposed structures of (A) SAMb. (B) SaMb and (C) &Mb [6-10,1sl. 
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Fig. 2. Electronic spectra (sodium phosphate buffer, pH 6.0, ,U = 0.10 M, 25.OT) of the met (---) deoxy (----) and CO-bound (....) forms of (A) 
native horse heart Mb, (B) green Mb, (C) red Mb and (D) green Mb reconstituted with fresh iron protoporphyrin IX. 
have been reported for samples of hemolysate taken 
from patients with sulphemoglobinemia [l 11. Prepara- 
tion of apo-Mb from the sample in Fig. 2B followed by 
reconstitution with fresh hemin, yields the spectrum 
shown in Fig. 2D, which is identical to that observed for 
native metMb. 
3.3. NA4R spectroscopy 
The ‘H NMR spectrum of the cyanmet form of native 
Mb is shown in Fig. 3A. The haem resonances a-h have 
been assigned previously for sperm whale [20] and horse 
heart [21] Mb. Fig. 3B shows the corresponding spec- 
trum for the cyanmet form of a sulphMb sample pre- 
pared in vitro as described above. The sample consists 
of sulphMb plus some unreacted native Mb (compare 
Figs. 3A and 3B). The major resonances observed in this 
spectrum correspond with those previously found for 
sulphMb [6,10], but some differences are apparent. In 
previous reports [6,10], three isomeric forms of sulphMb 
were identified, SAMb, &Mb and &Mb. The relative 
amounts of these components depend on oxidation state, 
solution pH, chromatographic methods employed and 
the age of the sample. We expect that sulphMb formed 
in vivo will be a similarly heterogeneous mixture, the 
spectroscopic properties of which are unlikely to dupli- 
cate exactly those of pure sulphMb isomers formed 
under controlled conditions in vitro. For this reason, we 
have not prepared purified sulphMb isomers. Our inten- 
tion is simply to establish a correlation between the con- 
taminating resonances in the NMR spectra of the red 
and green samples with those observed in authentic 
sulphMb samples. 
The prominent resonance in the spectrum of the 
sulphMb sample observed at 44.3 (i), 38.3 (j), 29.5 (k), 
25.6 (1) 24.3 (m), 20.0 (n), 9.7 (0) and 9.3 (p) ppm can 
also be identified in the green (44.1, 38.1,29.3,25.5, 24.1, 
9.5 and9.1 ppm) and red (44.4, 38.2, 29.5, 25.6 and 24.3 
ppm) samples, Fig. 3C and D. Peaks o and p are not 
significant contaminants in the red sample. By compari- 
son with published resonance assignments for the cy- 
anmet forms of each of the three isomeric forms, S,Mb, 
Z&Mb and &Mb, we see that only SAMb (peaks i, 1, m, 
and n) and S,Mb (peaks j and k) are present in our 
samples, with no contamination from &Mb. Neverthe- 
less, the presence other presumed forms of sulphMb [lo] 
are evident from the presence of the resonances labelled 
‘x’ in Fig. 3 that are not attributable to either S,Mb, 
S,Mb, &Mb or native Mb. Examination of the relative 
intensities of the methyl resonances for S,Mb (i), &Mb 
(j) and native Mb (1) in Fig. 3C and D reveals that the 
total amount of these two sulphMb forms is approxi- 
mately the same in both the green (- 16%) and red (- 17%) 
samples. However, the relative amounts of each of the 
isomers differ. For the green sample the main contami- 
nant is S,Mb (13% S*Mb, 3% $&Mb), while for the red 
sample the main contaminant is S,Mb (5% S,Mb, 12% 
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S,Mb). Reconstitution of the green sample from Fig. 3C 
yields the spectrum shown in Fig. 3E, which is identical 
to that of native Mb (Fig. 3A). 
4. Discussion 
From the results outlined above, it is clear that the 
expression system previously described [4] for efficient 
production of horse heart Mb can produce substantial 
quantities of sulphMb derivatives. The molecular masses 
for the green and red apo-Mb derivatives obtained from 
electrospray mass spectrometry measurements, com- 
bined with the conversion of the green form to native 
metMb following reconstitution with protohaem IX, 
provide compelling evidence for the integrity of the apo- 
protein and chemical modification of the prosthetic 
group as expected for sulphMb. We also note that SAMb, 
&Mb and ScMb are known to be unstable to decay to 
native deoxyMb following deoxygenation with dithionite 
[lo]. Presumably, this treatment would provide an alter- 
native method for removal of sulphmyoglobin contami- 
nation from our samples, though it is not clear whether 
the unidentified sulphMb products responsible for the 
resonances labelled ‘x’ in Fig. 3 would be similarly elim- 
inated. 
The presence of S,Mb and &Mb with no evidence for 
the formation of ScMb is consistent with work in vitro 
[lo] showing that the most effective routes for the forma- 
tion of &Mb are through incubation of sulphMb with 
CO (22°C 3 days) or cyanide (4°C 2 months). As our 
protein was never exposed to these conditions, formation 
Table I 
Absorption maxima (nm) for native Mb, sulphMb @Mb), green Mb 
(GMb), red Mb (RMb) and reconstituted green Mb (GMb,,) 
Protem Soret Visible 
Native Mb 
Fe(II1) 
Fe(H) 
Fe(II)CO 
SMb 
Fe(II1) 
Fe(I1) 
Fe(II)CO 
GMb 
Fe(II1) 
Fe(I1) 
Fe(II)CO 
RMb 
Fe(II1) 
Fe(I1) 
Fe(II)CO 
GMb,,,, 
Fe(II1) 
Fe(I1) 
Fe(II)CO 
408 502, 630 
435 560 
424 540, 579 
404 593 
421 508, 545, 570. 617 
422 613 
407.5 503, 596 
431 556. 619.5 
422 541, 551, 620.5 
407 503, 596 
431 559,622 
422 540.5, 576.5, 619 
408 503, 631 
434.5 559.5 
424 539.5, 578.5 
of &Mb is not expected. Formation of small amounts 
(3-10%) of &Mb upon incubation of metaquo-sulphMb 
at 22°C for 8 hours was also reported [lo], however, we 
see no evidence for formation of &Mb by this route. 
Interestingly, the total amount of sulphMb in the green 
and the red samples is the approximately the same (- 16% 
and - 17% respectively), while the relative amounts of 
S,Mb and &Mb isomers differ. Presumably, this finding 
results from the observation that S,Mb forms from the 
initial product, S,Mb [lo], so that the difference between 
the red and green cultures lies not in the total amount of 
S,Mb formed initially, but in the relative rates of conver- 
sion of S,Mb to &Mb. As the conversion of S,Mb to 
&Mb is dependent on pH, oxidation state, ligation state, 
temperature and time [lo], small changes in any of these 
variables under the growth conditions employed could 
account for the varying amounts of S,Mb observed. 
The source of the sulphur required for formation of 
sulphMb may be related to the source of the so-called 
‘inorganic’ or ‘labile’ sulphur implicated in formation of 
iron-sulphur clusters (e.g. ferredoxins, HiPIPs. nitroge- 
nase). Although little information is available concerning 
mobilization of this sulphur for formation of clusters, it 
is known that cysteine is the probable source in E. coli. 
[23]. Significantly, recombinant expression of iron- 
sulphur proteins requires no additional sulphur supple- 
ments to the growth media, so we, therefore, expect that 
sufficient concentrations of free sulphide exist under our 
growth conditions to account satisfactorily for the for- 
mation of sulphMb. The origin of the oxidising equiva- 
lents necessary for formation of the ferrylMb intermedi- 
ate is also of concern. Efficient sulphMb preparation in 
vitro requires formation of ferrylMb with hydrogen per- 
oxide, although simple exposure of oxyhemoglobin to 
H,S gas is sufficient to produce the characteristic green 
colour of sulphMb [24]. In the presence of excess oxygen, 
oxyMb autooxidises to form metMb plus superoxide 
anion radical [25]. Trace amounts of superoxide thus 
formed could decay according to the following schemes: 
O;- + 0; + Hz0 + HzO, + 0, + 20H- 
0.; + 2H’ -_) H20, + O2 
As the Mb produced during bacterial expression is a 
mixture of oxyMb and methlb, this mechanism could 
account for the presence of transient amounts of H20, 
in vitro and the subsequent formation of sulphMb. 
The observations reported here do not necessarily 
imply that formation of recombinant sulphMb is a char- 
acteristic of other reported Mb expression systems be- 
cause critical, poorly defined differences in bacterial 
strains, media, and precise growth conditions undoubt- 
edly influence the formation of this derivative. Neverthe- 
less, Olson and co-workers have noted the need to re- 
move small amounts of a green component from some 
recombinant sperm whale Mb preparations [26], and 
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Fig. 3. ‘H NMR spectra (200 MHz) of horse heart cyanmetMb derivatives (50 mM sodium phosphate buffer, pH* 7.0, 20°C). (A) native Mb, (B) 
sulphMb prepared in vitro, (C) green Mb, (D) red Mb and (E) green Mb reconstituted with fresh iron protoporphyrin IX. Cyanmet derivatives were 
obtained by addition of five equivalents of KCN to ferriMb. 
preparation of recombinant human Mb is reported [l] to 
require reconstitution with fresh hemin, which could ac- 
count for the absence of spectroscopic anomalies with 
this system. An additional consideration in the produc- 
tion of recombinant heme proteins is indicated by a re- 
cent NMR study of recombinant human Hb expressed 
in E. coli [27] demonstrating that heme inserted into 
recombinant hemoglobin may not always achieve the 
correct orientation. Finally, the aberrant spectroscopic 
forms of recombinant cytochrome c peroxidase previ- 
ously observed [28] may be related in part to the low level 
of heme incorporation into the recombinant peroxidase 
by E. coli and our observation is that this recombinant 
holoprotein exhibits an electronic absorption spectrum 
markedly different from that of the native protein (J.C. 
Ferrer and A.G. Mauk, unpublished). 
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